Skip to main content
SpringerLink
Log in

Influence of a niosomal formulation on the oral bioavailability of acyclovir in rabbits

  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

The purpose of this research was to prepare acyclovir niosomes in a trial to improve its poor and variable oral bioavailability. The nonionic surfactant vesicles were prepared by the conventional thin film hydration method. The lipid mixture consisted of cholesterol, span 60, and dicetyl phosphate in the molar ratio of 65:60:5, respectively. The percentage entrapment was ∼11% of acyclovir used in the hydration process. The vesicles have an average size of 0.95 µm, a most probable size of 0.8 µm, and a size range of 0.4 to 2.2 µm. Most of the niosomes have unilamellar spherical shape. In vitro drug release profile was found to follow Higuchi’s equation for free and niosomal drug. The niosomal formulation exhibited significantly retarded release compared with free drug. The in vivo study revealed that the niosomal dispersion significantly improved the oral bioavailability of acyclovir in rabbits after a single oral dose of 40 mg kg−1. The average relative bioavailability of the drug from the niosomal dispersion in relation to the free solution was 2.55 indicating more than 2-fold increase in drug bioavailability. The niosomal dispersion showed significant increase in the mean residence time (MRT) of acyclovir reflecting sustained release characteristics. In conclusion, the niosomal formulation could be a promising delivery system for acyclovir with improved oral bioavailability and prolonged drug release profiles.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Erlich KS. Management of herpes simplex and varicella-zoster virus infections.West J Med. 1997;166:211–215.

    PubMed  CAS  Google Scholar 

  2. Miranda P, Krasny HC, Page DA, Elion CB. Species differences in the disposition of acyclovir.Am J Med. 1982;73:31–35.

    Article  PubMed  Google Scholar 

  3. de Miranda P, Blum MR. Pharmacokinetics of acyclovir after intravenous and oral administration.J Antimicrob Chemother. 1983;12:29–37.

    PubMed  Google Scholar 

  4. Vergin H, Kikuta C, Mascher H, Metz R. Pharmacokinetics and bioavailability of different formulations of acyclovir.Arzneim Forsch. 1995;45:508–515.

    CAS  Google Scholar 

  5. Amidon GL, Lennernas H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of n vitro drug product dissolution and in vivo bioavailability.Pharm Res. 1995;12:413–420.

    Article  PubMed  CAS  Google Scholar 

  6. US FDA. Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid dosage forms based on a biopharmaceutics classification system. 2000; Available at: www.fda.gov/cder/guidance/2062dft.pdf. Accessed November 2, 2007.

  7. Avdeef A. pH-metric solubility. I. Solubility-pH profiles from Bjerrum plots, Gibbs buffer and pKa in solid state.Pharm Pharmacol Commun. 1998;4:165–178.

    CAS  Google Scholar 

  8. Lund W.The Pharmaceutical Codex, Principles and Practice of Pharmaceutics. London, UK: The Pharmaceutical Press; 1994.

    Google Scholar 

  9. Krenitsky TA, Hall WW, de Miranda P, Bauchamp LM, Schaeffer HJ, Whiteman P. 6- Deoxyacyclovir: a xanthine oxidase-activated prodrug of acyclovir.Proc Natl Acad Sci USA. 1984;81:3209–3213.

    Article  PubMed  CAS  Google Scholar 

  10. Lycke J, Malmestrom C, Stahle L. Acyclovir levels in serum and cerebrospinal fluid after oral administration of valacyclovir.Antimicrob Agents Chemother. 2003;47:2438–2441.

    Article  PubMed  CAS  Google Scholar 

  11. Luengo J, Aranguiz T, Sepulveda J. Preliminary pharmacokinetic study to different preparations of acyclovir with β-cyclodextrin.J Pharm Sci. 2002;91:2593–2598.

    Article  PubMed  CAS  Google Scholar 

  12. Azmin MN, Florence AT, Handjani-Vila RM, Stuart FB, Vanlerberghe G, Whittaker JS. The effect of non-ionic surfactant vesicles (niosome) entrapment on the absorption and distribution of methotrexate in mice.J Pharm Pharmacol. 1985;37:237–242.

    PubMed  CAS  Google Scholar 

  13. Peh KK, Yuen KH. Simple high-performance liquid chromatographic method for the determination of acyclovir in human plasma using fluorescence detection.J Chromatogr B. 1997;693:241–244.

    Article  CAS  Google Scholar 

  14. McIntosh TJ. The effect of cholesterol content on the structure of phosphatidylcholine bilayers.Biochim Biophys Acta. 1978;51:43–58.

    Google Scholar 

  15. Yoshioka T, Sternberg B, Florence AT. Preparation and properties of vesicles (niosomes) of sorbitan monoesters (span 20, 40, 60, 80) and a sorbitan triester (span 85).Inter J Pharmaceut. 1994;105:1–6.

    Article  CAS  Google Scholar 

  16. Schwender RA, Asanger M, Weder HG. N-alkyl-glucosides as detergents for the preparation of highly homogenous bilayer liposomes of visible size (60–240 nm) applying defined rates of detergent removal by dialysis.Biochem Biophys Res Commun. 1981;10:1055–1062.

    Article  Google Scholar 

  17. Brigden D, Fowle A, Rosling A. Collier LH, Oxford J, eds.Developments in Antiviral Therapy. London, UK: Academic Press; 1980:53–62.

    Google Scholar 

  18. Meadows KM, Dressman JB. Mechanism of acyclovir uptake in rat jejunum.Pharm Res. 1990;7:299–303.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Tanta, Tanta, Egypt

    Ismail A. Attia, Sanaa A. El-Gizawy, Medhat A. Fouda & Ahmed M. Donia

Authors
  1. Ismail A. Attia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sanaa A. El-Gizawy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Medhat A. Fouda
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ahmed M. Donia
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sanaa A. El-Gizawy.

Additional information

Published: December 14, 2007

Rights and permissions

Reprints and permissions

About this article

Cite this article

Attia, I.A., El-Gizawy, S.A., Fouda, M.A. et al. Influence of a niosomal formulation on the oral bioavailability of acyclovir in rabbits. AAPS PharmSciTech 8, 106 (2007). https://doi.org/10.1208/pt0804106

Download citation

  • Received:

  • Revised:

  • Accepted:

  • DOI: https://doi.org/10.1208/pt0804106

Keywords

Search

Navigation